How to Pick the Right Stop-Loss Attachment Point (Without Guessing)

What Is a Stop-Loss Attachment Point?

A stop-loss attachment point is the dollar threshold where your reinsurer starts paying. Below it, you absorb the claim. Above it, the carrier picks up the rest.

There are two types. Individual stop-loss (ISL) protects against any single claimant's costs exceeding a set limit. Aggregate stop-loss (ASL) caps your total plan claims for the year. Most self-funded employers carry both.

For mid-market employers (100-500 employees), ISL attachment points typically range from $100,000 to $500,000. The Aegis Risk Stop Loss Premium Survey shows the cost difference is dramatic: $229 PEPM at a $100,000 deductible versus $51 PEPM at $500,000. That gap is real money. It's also where most employers make their biggest mistake.

Why Does the Attachment Point Matter More Than the Premium?

Most employers pick their ISL level by asking their broker what's standard. That's not a strategy. That's a guess with a premium quote attached.

The right attachment point isn't a round number your carrier suggested. It's the point where you statistically expect one to three claimants to breach the threshold in a given year. The Society of Actuaries Health Watch Newsletter illustrates this directly. For a 251-member group with a $50,000 specific attachment point, a stop-loss carrier can recoup aggregating specific deductible costs from just two or three claims.

Set the threshold so high that statistically zero members breach it, and you don't need the coverage. Set it so low that five or more breach it every year, and you're buying first-dollar coverage at catastrophic prices. Your balance sheet tolerance should drive the number, not the carrier's default offer.

How Big Are Catastrophic Claims Getting?

The tail is real. And it's getting bigger fast.

According to the Voya Financial Stop Loss Paid Claims Analysis 2025, the largest individual stop-loss claim in 2024 was $8,873,908 for congenital anomalies. The top eight claims ranged from $5.6 million to $8.9 million, spanning cancer, respiratory disease, digestive disease, injury, cardiovascular, musculoskeletal, and premature birth.

These aren't outliers from Fortune 500 populations. A premature birth. A cancer case. A catastrophic injury. These happen at 200-employee companies. The top 1% of claimants drive roughly 22% of all healthcare spending. The top 5% drive half. Your stop-loss attachment point is a bet on whether that top 1% includes one of your employees this year.

The frequency of $1M+ claims has surged over 60% in the past four years, with a 30% jump in 2024 alone. Sun Life reported a 61% frequency increase from 2021 to 2024. TMHCC reported 113%. Total claim dollars on claims exceeding $2 million increased 96% from 2024 to 2025. In 2024, 49% of plans reported at least one $1M+ claim, up from 23% the year before.

Gene therapies are accelerating the problem. A single treatment can exceed $3-4 million. The specialty drug pipeline through 2027 includes dozens of cell and gene therapies heading toward FDA approval. One claimant on one of these treatments blows through any attachment point under $500,000.

What's Driving Stop-Loss Premiums Up in 2025-2026?

Segal's 2025 national dataset shows an average stop-loss premium increase of 9.7% across 221 health plans. The IFEBP survey confirms annual increases ranging from 8.8% to 10.5%, with longer-term growth reaching 12.1%. Some employers with poor claims experience are seeing increases closer to 20%.

Three forces are compounding:

• GLP-1 drugs. Some plans now report up to 9% of prescription costs going to GLP-1 medications alone. BCBS projects covering GLP-1s could drive employer premiums up by as much as 14%, and that's from just one drug class.
• Gene and cell therapy. Single treatments routinely exceed $1M. Stop-loss carriers are pricing this risk into every renewal, even for groups that haven't had a gene therapy claim yet.
• Reinsurance market hardening. Several of the largest stop-loss writers, including Cigna, Voya, and Sun Life, had rough claims experience in Q4 2024 due to advanced cancer treatments, premature births, and hospital systems pushing revenue through surgical and acute care. All of this flows into 2026 rate increases.

The Guy Carpenter Stop Loss Market Update adds another wrinkle. Injectable drugs above the $2 million attachment point have experienced higher trend than all other service categories combined. Raising your attachment point to save premium doesn't eliminate the risk. A single specialty drug case can push past $2 million on its own.

How Should You Calculate Your ISL Attachment Point?

Start with your group size and expected annual claims. Your TPA or actuary can model a claims distribution. You're looking for the threshold that produces one to three expected breaches per year across your population.

Ask your stop-loss carrier or actuary these three questions before you finalize a number:

• At this attachment point, how many members are statistically expected to breach it in year one?
• What's the probability of a single claim exceeding $2 million in our group?
• How does our Rx trend affect expected specific claim frequency at each ISL option?

Guy Carpenter's data confirms that Rx trends run higher at lower attachment points, while inpatient trends are comparatively lower there. A lower ISL doesn't just cost more in premium. It also means your carrier absorbs more volatile pharmacy risk, and they price accordingly.

One more thing to model: leveraged trend. While base medical trend runs around 4% annually, the leveraged effect at higher attachment points can reach 20% or more. A 4% increase in underlying claims pushes disproportionately more claims above your attachment threshold. Carriers price for this. You should too.

Pull your mid-year claims data before renewal season. Run expected breach probability against your group. Make sure what you're retaining matches what your balance sheet can actually absorb. Build this analysis into your 5-Year Benefits Blueprint so it's a recurring exercise, not a scramble every renewal.

What About Aggregate Stop-Loss?

Aggregate stop-loss caps your total plan claims for the year. The typical attachment point is 125% of expected claim cost, meaning you're responsible for claims up to 25% above expected before the carrier steps in. Smaller employers can sometimes negotiate a tighter corridor.

Aggregate matters most for smaller groups where a handful of claims can swing total plan cost by 30% or more in a single year. For a 150-employee company, two or three large claimants can push total claims well past 125% of expected. For a 500-employee company, statistical smoothing makes aggregate breaches less likely.

The math: take your expected annual claims, multiply by 1.25. That's your aggregate floor. Everything below it stays on your balance sheet. Make sure your cash reserves can absorb a bad year up to that threshold.

What Is Lasering and How Should You Handle It?

Lasering is when a stop-loss carrier sets a higher individual deductible for a specific known high-cost claimant. The carrier "laser-focuses" on that person and either excludes them from coverage entirely or raises their individual attachment point far above the group level.

A common example: your group has a $200,000 ISL, but one member with a known cancer diagnosis gets lasered at $500,000. The first $500,000 of their claims stays on your plan. The carrier only covers the excess.

Lasering is becoming more common as large claims accelerate. Carriers use it to manage known risk they've already identified in your claims data. Your options: accept the laser and budget for the retained risk, negotiate a buyout premium to remove it, or shop your stop-loss to carriers willing to cover the member at the standard level.

The worst move is ignoring a laser and treating it like a standard renewal. A single lasered claimant can create a six-figure gap between what you think you're covered for and what you actually are. Flag every laser to your broker at renewal and model the financial exposure.

What About Captives and Alternatives?

Group captives are gaining traction among mid-market employers. Willis Towers Watson reports that over 40% of employers are either using or evaluating captive structures. Most growth is among groups with fewer than 500 employees.

A group captive pools unrelated employers into a collective insurance entity. Members share risk and benefit from the group's combined claims experience. The structure gives mid-market employers access to stop-loss pricing and risk management tools that were previously available only to large, self-insured corporations.

Credible estimates say group captives can work for employers with as few as 50 covered lives. The key requirement is a commitment to ongoing risk management, not just cheaper premiums. Captives that treat the structure as a cost arbitrage without investing in claims management and proactive strategies tend to underperform.

Level-funded plans offer a different trade-off. You pay a fixed monthly amount covering claims, admin, and stop-loss. Underspend gets refunded. The predictability appeals to CFOs, but the stop-loss embedded in level-funded products is often less flexible than standalone stop-loss. The attachment points, contract terms, and carrier selection are bundled. You lose the ability to negotiate each piece independently.

What Do Employers Get Wrong Most Often?

Five patterns show up consistently:

• Setting the attachment too low. A $50,000 or $75,000 ISL turns your stop-loss carrier into a claims administrator. You're paying catastrophic-level premiums for protection that kicks in on routine large claims. Premium leverage works against you at low attachment points.
• Setting it too high to save premium. A $500,000 ISL looks cheap until you absorb a $450,000 cancer case that your balance sheet wasn't built for. Premium savings mean nothing when a single claim creates a cash crisis.
• Not adjusting for medical trend. Your attachment point from three years ago is worth less today. Medical trend running at 8-10% means a $200,000 attachment point from 2023 is effectively $160,000 in today's claim dollars. Carriers adjust their pricing for trend. You need to adjust your retained risk for it too.
• Ignoring terminal liability. When you switch stop-loss carriers, claims incurred during the old policy period but paid after it ends can fall into a coverage gap. Run-out provisions vary by carrier. Some cover 12 months of run-out. Others don't. Missing this creates exposure on your largest, longest-running claims, exactly the ones stop-loss exists to cover.
• Treating renewal as a formality. Accepting every renewal without modeling your claims distribution, benchmarking your attachment point, and checking for lasers is how you overpay and underprotect simultaneously.

What Should You Do Before Your Next Renewal?

Pull your claims data. Run a frequency analysis on claimants near and above your current attachment point. Model the expected breach count at two or three different ISL levels. Compare the premium difference against the retained risk at each level.

Check every laser. Model the financial exposure of each one. Decide whether to accept, negotiate a buyout, or shop the risk.

Evaluate your aggregate corridor. Make sure your cash reserves cover a bad year up to 125% of expected. Track your Benefits Control System metrics quarterly so you're not starting from scratch at renewal.

The stop-loss market is hardening. Reinsurance pricing is up 15%. Million-dollar claims are surging. GLP-1s and gene therapies are rewriting the risk math. The employers who navigate this well are the ones who treat attachment point selection as an actuarial decision, not a broker suggestion. Use your Compliance Calendar to build stop-loss renewal into your annual planning cycle at least 120 days before expiration.